Prochin and NattoPharma join forces in China

Shanghai ProChin, part of the Alliance Nutrition Group, and NattoPharma have joined forces in China.

NattoPharma is dedicated to delivering premium products proven beneficial for human health through extensive clinical study. This commitment has created patented intellectual properties that provide companies with unsurpassed opportunities to revolutionize their markets.

With welcoming NattoPharma, Shanghai Prochin has expanded their list of speciality dairy ingredients with MenaQ7 – Vitamin K2 and MK-7.

MenaQ7® is the first and most clinically validated Vitamin K2 as MK-7 (menaquinone-7) available today for bone and cardiovascular health, and patented for cardiovascular health.

MK-7 is recognized in scientific literature for providing optimal activity and vitamin K status in the body, supporting bone and cardiovascular health, and MenaQ7® has demonstrated these strengths and benefits in human clinical trials with adult and child populations.

Meeting the demands of an increasingly growing global market for health solution products, MenaQ7® varieties are suitable for vegans and vegetarians, free from gluten, dairy, and other known allergens.

Since MenaQ7® was first introduced, novel technologies have been pioneered to expand the product portfolio. Today, the MenaQ7® product range caters to a growing global demand of high-purity, stable, and well-researched Vitamin K2 as MK-7.

Leave a reply